Objective To determine the survival outcome and prognostic factors of hepatocellular
carcinoma (HCC) survival in patients who underwent radiofrequency ablation (RFA) …

Aim To evaluate the incidence of adverse events and associated factors after radiofrequency
ablation (RFA) in patients with hepatocellular carcinoma within 30 days. Materials and …

Abstract Background and Aims: We evaluated the prognosis and associated factors in
patients with small hepatocellular carcinoma (HCC; up to 3 nodules, each up to 3cm in …

PURPOSE: To evaluate the pattern and risks for intrahepatic recurrence after percutaneous
radiofrequency (RF) ablation for hepatocellular carcinoma (HCC). MATERIALS AND …

Objectives: The aim of this study was to compare the clinical effectiveness and cost of
percutaneous radiofrequency ablation (PRFA) and surgical resection (SRS) for the …

Objective To compare the effectiveness of percutaneous radiofrequency ablation (PRFA)
and surgical resection as an initial treatment for patients with small hepatocellular carcinoma …

OBJECTIVES: Radiofrequency ablation (RFA) is widely performed for hepatocellular
carcinoma (HCC). However, there has been no report on 10-year outcome of RFA. The …

The treatment of hepatocellular carcinoma (HCC) is a significant challenge. Although
radiofrequency ablation (RFA) has emerged as a popular therapeutic option for patients with …

Objectives The purpose of this study was to evaluate the 10-year overall survival and local
tumor progression (LTP) of percutaneous radiofrequency ablation (RFA) for single nodular …

AIMS: To assess whether combining percutaneous radiofrequency ablation (PRFA) with
transcatheter arterial chemoembolization (TACE) was better than PRFA alone for …